Creo Medical’s second robotics agreement for its Kampative technology, this time with CMR Surgical for integration into its Versius Surgical Robotic System is a further industry validation of the technology, according to broker Cenkos.
Creo continues to demonstrate progress with its Build, Buy and Partner strategy.
This strategy will see the company continue to develop and commercialise its core suite of endoscopic devices, powered by the CROMA Advanced Energy Platform, buy businesses which can enhance its distribution, particularly in the US, and partner its technology platforms in adjacent markets in which Creo itself will not compete directly.
Buy is the house broker’s recommendation.